Quest Diagnostics Incorporated DGX
262.21 USD +2.61 (+1.01%)
Regular-session close
262.21 0.00 0.00%
After hours · Nov 16, 4:11 PM ET
260.76 Day range 263.19
171.18 52-week range 263.19
- YTD
- +51.10%
- 1 year
- +40.26%
Benzinga news
benzinga.com Quest Diagnostics Bumps Guidance While Managing Quanum System Breach Quest Diagnostics tops Q3 estimates, raises full-year 2026 guidance, and addresses an unauthorized Quanum LSM cybersecurity event.
benzinga.com Quest Diagnostics Q3 2026 Earnings Call Transcript Quest Diagnostics (NYSE:DGX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…benzinga.com Quest Diagnostics Discloses Unauthorized Access To Its Testing Management Platform Quanum LSM System; Company Promptly Initiated Its Cybersecurity Incident Response Procedures To Contain The Activity; Sees No Material Disruption On October 21, 2026, Quest Diagnostics Incorporated (the "Company") learned of unauthorized access to its Quanum LSM system, which certain clients use to place test orders, receive and look up…
benzinga.com Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 Est Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 analyst estimate..
benzinga.com Quest Diagnostics Raises FY2026 Adj EPS Guidance from $11.05-$11.25 to $11.25-$11.35 vs $11.19 Est; Raises FY2026 Sales Guidance from $11.950B-$12.050B to $12.065B-$12.105B vs $12.001B Est Quest Diagnostics (NYSE:DGX) raises FY2026 Adj EPS guidance from $11.05-$11.25 to $11.25-$11.35 vs $11.19 analyst estimate. Raises FY2026 sales outlook from $11.950 billion-$12.050 billion to $12.065…
benzinga.com Quest Diagnostics Q3 Adj. EPS $3.00 Beats $2.86 Estimate, Sales $3.097B Beat $3.046B Estimate Quest Diagnostics (NYSE:DGX) reported quarterly earnings of $3.00 per share which beat the analyst consensus estimate of $2.86 by 4.9 percent. This is a 15.38 percent increase over earnings of $2.60…
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Vivos Therapeutics (NASDAQ:VVOS) stock increased by 17.9% to $0.16 during Monday's after-market session. The market value of their outstanding shares is at $2.8 million. SCWorx (NASDAQ:WORX)…
